ARTICLE | Company News
Prizm other research news
April 15, 2013 7:00 AM UTC
Prizm received a $100,000 Phase I SBIR grant from the U.S. Public Health Service to develop its technology for targeting gene expression to selected tissues. The company will direct systemically deliv...